Filter Reports by Region
sale
Efavirenz Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Efavirenz is an anti-HIV drug that slows down the damage to immune system and prevents occurrence of AIDS-related illnesses. It belongs to a family of drugs known as nonnucleoside reverse transcriptase inhibitors, which converts single-stranded viral RNA into a double-stranded DNA.
Report Code : A14415 | Category : Life Sciences
